Histone deacetylase inhibitor, apicidin, inhibits human ovarian cancer cell migration via class II histone deacetylase 4 silencing

Mee Young Ahn, Dong O. Kang, Yong Jin Na, Sungpil Yoon, Whan Soo Choi, Keun Wook Kang, Hae Young Chung, Jee H. Jung, Do Sik Min, Hyung Sik Kim

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

This study examined the molecular mechanisms of apicidin in the modulation of human ovarian cancer SKOV-3 cells invasion and migration. Apicidin markedly decreased histone deacetylase 4 (HDAC4) expression and blocked cell migration and invasion. Cell migration was inhibited via down-regulation of matrix metalloproteinase-2 (MMP-2) and up-regulation of RECK in the HDAC4-blocked SKOV-3 cells. Apicidin significantly suppressed the binding of HDAC4 to Sp1 binding elements of the RECK promoter via repression of HDAC4. In an in vivo model, apicidin suppressed the growth of transplanted SKOV-3 cells by down-regulating HDAC4 and MMP-2. Apicidin may potentially be used as an anti-cancer agent for inhibition of cancer cell migration and invasion through the repression of MMP-2 which is related to the reduction of HDAC4.

Original languageEnglish
Pages (from-to)189-199
Number of pages11
JournalCancer Letters
Volume325
Issue number2
DOIs
Publication statusPublished - 2012 Dec 28

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Histone deacetylase inhibitor, apicidin, inhibits human ovarian cancer cell migration via class II histone deacetylase 4 silencing'. Together they form a unique fingerprint.

  • Cite this

    Ahn, M. Y., Kang, D. O., Na, Y. J., Yoon, S., Choi, W. S., Kang, K. W., Chung, H. Y., Jung, J. H., Min, D. S., & Kim, H. S. (2012). Histone deacetylase inhibitor, apicidin, inhibits human ovarian cancer cell migration via class II histone deacetylase 4 silencing. Cancer Letters, 325(2), 189-199. https://doi.org/10.1016/j.canlet.2012.06.017